Henan Lingrui Pharmaceutial Co., Ltd.SSE: 600285

(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing

Oct 30, 2026 · Issued by Henan Lingrui Pharmaceutial Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600285 · Oct 30, 2026

On 6ix: 6ix.com/news/600285henan-lingrui-pharmaceutical-co-ltdannouncement-on-convening-the-q3-2026-performance-briefing

Announcement on Convening the Q3 2026 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Henan Lingrui Pharmaceutial Co., Ltd. on 6ix

Story so far

(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge of Certain Shares Held by Major ShareholderOct 14, 2026
(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major ShareholderSep 30, 2026
Announcement on Pledge of Certain Shares Held by Major ShareholderAug 22, 2026

Earlier from Henan Lingrui Pharmaceutial

(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge of Certain Shares Held by Major ShareholderOct 14
(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major ShareholderSep 30
Announcement on Pledge of Certain Shares Held by Major ShareholderAug 22
Semi-annual Report for 2026Aug 12
Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"Jul 11

All Henan Lingrui Pharmaceutial news releases

Follow Henan Lingrui Pharmaceutial into a list and get an email when it puts out news.

Follow Henan Lingrui Pharmaceutial